drugset / Trial / NCT06225752
Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
Phase 3
Recruiting
5452 enrolled
First Affiliated Hospital of Wannan Medical College
Beijing Tiantan Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis.
Timeline
- Start
- 2024-06-15
- Primary completion
- 2026-04-30
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Probucol | Small molecule | 250 mg | — |